Monday, 28 May 2018

You are here

NLRP3 Activation in Still's Disease

Adult-onset Still disease (AOSD) is usually regarded as an autoinflammatory disease, largely because of its symptomatology and responsiveness to IL-1 inhibition.  Thus while it is assumed that aberrant NLRP3 inflammasome activity underlies active AOSD, the connection between NLRP3 AOSD has yet to be solidfied.

Hseih et al have studied mRNA expression of NLRP3 inflammasome signaling using quantitative-PCR (qPCR) on peripheral blood mononuclear cells (PBMC) from 34 patients with AOSD and 14 healthy subjects. These results were either augmented with a NLRP3 activator [imiquimod (IMQ)] or inhibitor.

AOSD patients demonstrated significantly higher mRNA levels of NLRP3 signaling compared with controls. Moreover, NLRP3 expression was positively correlated with AOSD disease activity

IMQ (a TLR7 ligand and activator) stimulated higher expression of NLRP3, caspase-1 and IL-18.  These were decreased after treatment with NLRP3 inhibitor in patients with AOSD.

Increased expression of NLRP3 inflammasome and its correlation with disease activity in AOSD suggest its involvement in disease pathogenesis of AOSD.  Currently the inducers of NLRP3 activity in AOSD are unknown and would make for an ideal treatment target in the future.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Autoinflammatory Syndromes Show Dramatic Response to Canakinumab

The New England Journal of Medicine reports that the anti-interleukin (IL)-1β monoclonal antibody canakinumab (Ilaris) was effective in the treatment of three distinct autoinflammatory recurrent fever syndromes (FMF, TRAPS, HIDS) with responses that were far superior to what was seen with placebo on almost every outcome measure, a randomized study found.

Treat-to-Target a Bust with Rheumatologists

Treat-to-target strategy is widely advocated as an important means of optimizing treatment responses in patients with rheumatoid arthritis. Even though T2T is encouraged by most guidelines, a current report shows that US Rheumatologists fail to implement T2T in their daily practice.

Epigenetic Link in Rheumatoid Arthritis to Huntington's Disease

Researchers at University of California San Diego School and the Icahn School of Medicine have found a high-resolution epigenomic landscape of rheumatoid arthritis (RA) that overlaps with that seen in Huntington's disease, suggesting potentially new unanticipated pathways that could be developed into therapeutic targets.

Mortality Predictors in Rheumatoid Arthritis

A population based study from southern Denmark finds excess mortality RF-positive males with rheumatoid arthritis (RA) and that employment status and comorbidity were independent predictors of mortality.

Investigators stuided 509 RA patients between 1995 to 2002, of whom 200 (39%) died during 6079 person-years of follow-up.

Genetic Breakthrough in Systemic JIA

The identification of a genetic susceptibility locus for systemic juvenile idiopathic arthritis (sJIA) has important implications for treatment of this severe, poorly understood illness, researchers reported.